Transcode Therapeutics
Price & Volume
Stats
See more52W Range | $3.21-$237.60 |
Market Cap | $2.4M |
Shares Short | 52,411 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $5,571.72 |
News
See moreYahoo Finance • last year
TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
Yahoo Finance • last year
Nasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions
Yahoo Finance • last year
TransCode Therapeutics Announces Public Offering of Common Stock
About
CEO | Mr. Thomas A. Fitzgerald M.B.A. |
CFO | Mr. Thomas A. Fitzgerald M.B.A. |
Address | 6 Liberty Square, Boston, MA, United States, 02109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
